125 related articles for article (PubMed ID: 32774260)
1. A Case of Advanced Gastroesophageal Junction Cancer with Bulky Lymph Node Metastases Treated with Nivolumab.
Nakamura N; Kinami S; Fujita J; Kaida D; Tomita Y; Miyata T; Fujita H; Ueda N; Takamura H; Kosaka T
Case Rep Oncol; 2020; 13(2):702-707. PubMed ID: 32774260
[TBL] [Abstract][Full Text] [Related]
2. [A Case of Effective Disease Control of Advanced Gastric Cancer with Distant Lymph Node Metastases Following Nivolumab Treatment].
Nakamura N; Kinami S; Fujita J; Kaida D; Tomita Y; Miyata T; Fujita H; Takamura H; Ueda N; Kosaka T
Gan To Kagaku Ryoho; 2020 Aug; 47(8):1258-1260. PubMed ID: 32829368
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Long Survival with Hilar Lymph Node Metastasis from Gastric Cancer Successfully Treated with Nivolumab Immunotherapy].
Okada K; Takeoka T; Kobayashi K; Fukunaga M
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2315-2317. PubMed ID: 32156916
[TBL] [Abstract][Full Text] [Related]
4. Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report.
Matsumoto R; Arigami T; Matsushita D; Okubo K; Tanaka T; Yanagita S; Sasaki K; Noda M; Kita Y; Mori S; Kurahara H; Ohtsuka T
World J Surg Oncol; 2020 Jul; 18(1):179. PubMed ID: 32693806
[TBL] [Abstract][Full Text] [Related]
5. Lymph Node Metastasis From Gastroesophageal Cancer Successfully Treated by Nivolumab: A Case Report of a Young Patient.
Kashima S; Tanabe H; Tanino M; Kobayashi Y; Murakami Y; Iwama T; Sasaki T; Kunogi T; Takahashi K; Ando K; Ueno N; Moriichi K; Fukudo M; Tasaki Y; Hosokawa M; Mizukami Y; Fujiya M; Okumura T
Front Oncol; 2019; 9():1375. PubMed ID: 31921639
[No Abstract] [Full Text] [Related]
6. Long-term survival achieved by repeated administration of ramucirumab after drug holidays due to proteinuria in recurrent gastric cancer.
Uehata N; Kouzu K; Tsujimoto H; Sugasawa H; Wakamatsu K; Kishi Y; Ueno H
Surg Case Rep; 2021 Apr; 7(1):97. PubMed ID: 33876326
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Advanced Esophagogastric Junction Adenocarcinoma with Enlarged Lymph Node Metastases of the Middle Mediastinum and Intraperitoneal That Exhibited pCR by Preoperative SOX Therapy].
Mita K; Oda H; Sato M; Takahashi K; Shimaguchi M; Kobayashi N; Kouno M; Toyota T; Toyota N; Hatano M; Sasaki J; Kawamura Y; Nishida K
Gan To Kagaku Ryoho; 2023 Aug; 50(8):909-912. PubMed ID: 37608419
[TBL] [Abstract][Full Text] [Related]
8. [A Case of Advanced Gastric Cancer in Which Tumor Relapse Was Observed after Discontinuation of Nivolumab Due to Complete Response, and for Which Re-Administration Was Initiated].
Nishida K; Yagi H; Mizumoto R; Haeno M; Mori S; Nomura M; Yasuyama A; Yoshikawa Y; Sueda T; Matsumura T; Koga C; Miyagaki H; Tei M; Tsujie M; Akamaru Y
Gan To Kagaku Ryoho; 2023 Mar; 50(3):343-345. PubMed ID: 36927904
[TBL] [Abstract][Full Text] [Related]
9. An unresectable gastric cancer with bulky lymph node metastases treated with SOX chemotherapy plus apatinib followed by D3 radical gastrectomy: a case report.
Zhang N; Deng J; Sun Y; Xiao J; Li H; Liang H
Transl Cancer Res; 2021 Jan; 10(1):537-545. PubMed ID: 35116283
[TBL] [Abstract][Full Text] [Related]
10. [A case of metastatic gastric cancer showing long-term control with nivolumab after pseudoprogression].
Okamoto T; Ueda S
Nihon Shokakibyo Gakkai Zasshi; 2021; 118(6):549-554. PubMed ID: 34108354
[TBL] [Abstract][Full Text] [Related]
11. A case of multiple metastatic gastric cancer with primary lesion vanished after administrating nivolumab, and the effect remains even after discontinuance of therapy.
Doi H; Ninomiya M; Toyota K; Hirahara S; Kuhara Y; Shirakawa K; Yano R; Kobayashi H; Hashimoto Y; Yokoyama Y; Sakashita Y; Miyamoto K
Int Cancer Conf J; 2020 Oct; 9(4):187-192. PubMed ID: 32904060
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4).
Boku N; Ryu MH; Kato K; Chung HC; Minashi K; Lee KW; Cho H; Kang WK; Komatsu Y; Tsuda M; Yamaguchi K; Hara H; Fumita S; Azuma M; Chen LT; Kang YK
Ann Oncol; 2019 Feb; 30(2):250-258. PubMed ID: 30566590
[TBL] [Abstract][Full Text] [Related]
13. Recurrent gastric cancer sustaining a partial response after the nivolumab discontinuation because of immune-related adverse events: a case report.
Arigami T; Matsushita D; Okubo K; Tanaka T; Sasaki K; Noda M; Kita Y; Mori S; Tsuruda Y; Kurahara H; Ohtsuka T
Surg Case Rep; 2020 Oct; 6(1):271. PubMed ID: 33074364
[TBL] [Abstract][Full Text] [Related]
14. [A Case of Initially Unresectable Advanced Gastric Cancer Radically Resected by Conversion Surgery after Nivolumab Immunotherapy].
Koizumi N; Kashiwagi S; Ogino S; Kamada Y; Fujiki H; Sakakura C
Gan To Kagaku Ryoho; 2020 Nov; 47(11):1624-1626. PubMed ID: 33268741
[TBL] [Abstract][Full Text] [Related]
15. [A Case of Multiple Lymph Node Metastases Treated with Nivolumab after an Adrenalectomy for Solitary Adrenal Metastasis of Gastric Cancer after a Gastrectomy].
Nakai M; Ichisawa A; Yamada T; Kimura T; Yonaiyama S; Jin H; Tokura T; Aoki K; Kawashima H; Toyoki Y; Endo M
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2434-2436. PubMed ID: 32156956
[TBL] [Abstract][Full Text] [Related]
16. [Long-Term Response of Nivolumab for Recurrent Lymph Nodes after Surgery for Gastric Cancer-A Case Report].
Katsuyama S; Takeno A; Masuzawa T; Sugimura K; Kihara Y; Haruna K; Shinke G; Ikeshima R; Kawai K; Hiraki M; Katsura Y; Ohmura Y; Hata T; Takeda Y; Murata K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1868-1870. PubMed ID: 35045431
[TBL] [Abstract][Full Text] [Related]
17. [Brain Metastasis Arising from Gastric Cancer during Long-Term Treatment Using Nivolumab].
Namikawa T; Marui A; Yokota K; Kawanishi Y; Munekage M; Uemura S; Maeda H; Kitagawa H; Nagata Y; Kobayashi M; Hanazaki K
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1544-1546. PubMed ID: 36733129
[TBL] [Abstract][Full Text] [Related]
18. Nivolumab exerts therapeutic effects against metastatic lesions from early gastric adenocarcinoma with a small proportion of neuroendocrine carcinoma after gastrectomy: a case report.
Sawayama H; Komohara Y; Hirao H; Sakata K; Takata N; Yoshinaka I; Harada K; Baba H
Clin J Gastroenterol; 2020 Oct; 13(5):759-765. PubMed ID: 32592148
[TBL] [Abstract][Full Text] [Related]
19. A case of primary malignant melanoma of the esophagogastric junction with abscopal effect after nivolumab administration.
Yamaguchi T; Fushida S; Kinoshita J; Saito H; Shimada M; Terai S; Moriyama H; Okamoto K; Nakamura K; Ninomiya I; Inaki N
Surg Case Rep; 2021 Dec; 7(1):253. PubMed ID: 34882298
[TBL] [Abstract][Full Text] [Related]
20. [Curative Resection for Advanced Gastric Cancer with Lymph Node Metastasis along the Middle Colic Artery].
Namikawa T; Shimizu S; Maeda M; Yokota K; Tanioka N; Munekage M; Uemura S; Maeda H; Kitagawa H; Kumon T; Kumon M; Kobayashi M; Hanazaki K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1564-1566. PubMed ID: 35046257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
